Tempest Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Tempest Therapeutics, Inc. (TPST) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents30.2739.2331.2351.8318.82
Cash & Short-Term Investments30.2739.2331.2351.8318.82
Accounts Receivable0.000.000.4515.000.26
Inventory0.000.000.000.000.00
Other Current Assets0.640.100.700.950.25
Total Current Assets31.4740.3632.9568.9619.83
Non-Current Assets
Property, Plant & Equipment (Net)9.5310.7912.714.162.99
Long-Term Investments0.390.000.000.000.00
Other Non-Current Assets0.490.450.430.110.05
Total Non-Current Assets10.0111.2413.144.280.00
Total Assets41.4951.6046.0973.2422.86
Current Liabilities
Accounts Payable2.450.851.110.991.07
Short-Term Debt6.354.290.000.000.00
Current Portion of Long-Term Debt6.354.290.000.000.00
Accrued Liabilities4.551.794.312.591.44
Other Current Liabilities4.551.540.4515.000.00
Total Current Liabilities14.229.417.2820.033.22
Non-Current Liabilities
Long-Term Debt8.146.2610.3715.070.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities8.1415.4220.7017.100.00
Total Liabilities22.3624.8427.9837.124.95
Stockholders' Equity
Common Stock0.040.020.010.010.00
Retained Earnings-207.11-165.26-135.77-100.06-71.76
Additional Paid-in Capital226.19192.01153.87136.170.00
Shares Outstanding3.381.700.810.530.00
Total Stockholders' Equity19.1326.7718.1136.1217.91
Total Liabilities & Equity41.4951.6046.0973.240.00